Study | Objective | Study design | Setting | Intervention and comparator | Comparator | Participants | Outcomes measured |
---|---|---|---|---|---|---|---|
Gador-Whyte et al. (2014) [31] Cost of Best practice care | To estimate, from a remote ACCHS perspective, the cost of completing best practice chronic care tasks for patients with type 2 diabetes and/or CKD. | Partial economic evaluation/costing study. | Australia, remote area; ACCHS in unnamed Central Australian Aboriginal community. | Best practice care for patients with diabetes and/or CKD. | Usual care delivery for patients with diabetes and/or CKD in that particular ACCHS setting | Patients: 205 Aboriginal patients: 74 had diabetes, 86 had CKD and 45 had both. | Costs: annual costs (total and per patient) of managing CKD and diabetes in 2009–2010 and projected annual costs using optimal PHC management; difference in these actual and projected costs. |
ACCHS staff: 4 AHWs, 3 nurses, 1 GP, 1 educator, 1 exercise physiologist. | |||||||
Conducted 2010–2011. | |||||||
Baker et al. (2005) [30] Menzies Renal Treatment Program | To assess, from a government health service perspective, if the MRTP reduced the costs of treating ESKD through improved clinical outcomes. | Economic evaluation. | Australia, remote area; ACCHS on Tiwi Islands, 80 km north of Darwin. | Program to modify kidney and cardiovascular disease. Antihypertensives and health education offered. | Usual Care | Intervention group: 258 Aboriginal patients with hypertension and/or CKD. | Health outcomes: Dialysis starts and dialysis person-years avoided. |
Comparator group: 229 Aboriginal patients in a historical control group (1992–1995). | Costs: MRTP delivery costs; ESKD treatment costs; total cost. | ||||||
Conducted 1995–2000. | Net cost of the program/savings compared to usual care. | ||||||
Measured at 3 and 4.7 years. |